BALTIMORE (WJZ)–A Baltimore company gets one step closer in the race to develop an Ebola vaccine.

Profectus Biosciences says after a successful animal trial–human trials of the vaccine are expected to begin in June.

Research shows it will be effective against the strain of the virus that’s killed more than 10,000 people in West Africa.